StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Stock Up 24.0 %
Avinger stock opened at $1.29 on Tuesday. The firm has a market cap of $2.20 million, a price-to-earnings ratio of -0.07 and a beta of 1.17. Avinger has a 52 week low of $0.90 and a 52 week high of $6.55. The business’s 50-day moving average price is $1.15 and its 200 day moving average price is $2.18.
Avinger (NASDAQ:AVGR – Get Free Report) last posted its earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million during the quarter, compared to analysts’ expectations of $2.55 million. Equities analysts expect that Avinger will post -4.69 EPS for the current year.
Institutional Trading of Avinger
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Recommended Stories
- Five stocks we like better than Avinger
- Are Penny Stocks a Good Fit for Your Portfolio?
- When Is the Best Time to Invest in Mutual Funds?
- What Are Dividends? Buy the Best Dividend Stocks
- Is NVIDIA Stock in a Correction or Consolidation?
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.